The stocks making the biggest moves in premarket trading include Gilead Sciences, Starbucks, BP, Coty, and more. : Gilead Sciences (GILD) – Gilead set pricing for its remdesivir anti-viral Covid-19 treatment, with developed-world governments paying $390 per dose and privately insured patients being charged $520 per dose. Intercept Pharmaceuticals (ICPT) – The Food and Drug Administration did not approve the company's treatment for obesity-linked liver disease. Intercept said it would meet with the FDA to discuss possible paths to approval.